TherapeuticsMD, Inc. (Nasdaq – TXMD)

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of TherapeuticsMD, Inc. (Nasdaq – TXMD) BALA CYNWYD – May 31, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (Nasdaq – TXMD) for possible breaches of … Continue reading TherapeuticsMD, Inc. (Nasdaq – TXMD)